Ahmad et al. [11] demonstrated that IL-10 has an inhibitory effect on the migration of breast cancer cell lines, and this study also found that breast cancer patients with higher IL-10 levels show better disease-free survival and breast cancer-specific survival in the early stages of invasive breast cancer. The gene discussed is IL10; the disease is breast carcinoma.